Medicine & Life Sciences
Peru
100%
Cost-Benefit Analysis
61%
entecavir
33%
Tenofovir
30%
Pneumococcal Vaccines
29%
Treatment Adherence and Compliance
27%
Chronic Hepatitis B
25%
Costs and Cost Analysis
24%
Interferons
21%
Multiple Sclerosis
20%
Antiviral Agents
20%
Tornadoes
19%
Pneumonia
19%
Health
15%
Gross Domestic Product
14%
Public Hospitals
13%
Vaccines
11%
Pneumococcal Pneumonia
11%
Child
10%
Quality-Adjusted Life Years
9%
Workforce
9%
Hospitalization
8%
Insurance Coverage
7%
Therapeutics
7%
Public Health
7%
Health Insurance
7%
Insurance
6%
Health Expenditures
6%
10-valent pneumococcal conjugate vaccine
6%
Health Care Costs
6%
Hepatitis B virus
5%
Economic Models
5%
Uncertainty
5%
Social Sciences
Peru
49%
Health sector
25%
contagious disease
23%
human resources
16%
drug
16%
insurance coverage
14%
reform
13%
costs
13%
public health
12%
health insurance
12%
willingness to pay
12%
insurance
11%
expenditures
10%
health
10%
ministry
9%
coverage
8%
drug abuse
8%
public spending
7%
health authorities
6%
life years
6%
pluralism
5%
gross domestic product
5%
minister
5%
Earth & Environmental Sciences
alternative energy
27%
energy
23%
auction
16%
transition
14%
matrix
10%
state owned enterprise
9%
institutional framework
7%
civil society
7%
regulatory framework
7%
climate change
6%
renewable resource
6%
liquefied natural gas
6%
electricity generation
6%
United Nations
6%
biofuel
6%
energy resource
6%
solar wind
5%
economic growth
5%
energy source
5%
twenty first century
5%
greenhouse gas emissions
5%
electricity
5%
natural gas
5%
power plant
5%